Optimer Pharmaceuticals, Inc.

10110 Sorrento Valley Rd
San Diego, CA 92121
http://www.cubist.com/

Market Performance

NASDAQ: OPTR
52 Week Low $N/A

SBIR Award Summary

Total Number of Awards 10
Total Value of Awards $5.33MM
First Award Date 08/01/03
Most Recent Award Date 09/01/09

Key Personnel

Last Name Name Awards Contact
Ichikawa Yoshitaka Ichikawa 2
Romero Alex Romero 3
Sucheck Steven J Sucheck 1
Shue Youe-Kong Shue 1
Babakhani Farah Babakhani 3

10 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 09/01/09 - 08/31/12

DESCRIPTION (provided by applicant): Clostridium difficile, a toxigenic, gram-positive anaerobic bacterium, is the most common cause of nosocomial diarrhea. Over the past 15 years there has been a steady increase in the incidence of Clostridium difficile- associated diarrhea (CDAD), a disease that is now epidemic in parts of North America and Eu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-34
Budget: 09/01/08 - 08/31/09

DESCRIPTION (provided by applicant): Clostridium difficile, a toxigenic, gram-positive anaerobic bacterium, is the most common cause of nosocomial diarrhea. Over the past 15 years there has been a steady increase in the incidence of Clostridium difficile- associated diarrhea (CDAD), a disease that is now epidemic in parts of North America and Eu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-34
Budget: 09/15/07 - 08/31/08

DESCRIPTION (provided by applicant): Clostridium difficile, a toxigenic, gram-positive anaerobic bacterium, is the most common cause of nosocomial diarrhea. Over the past 15 years there has been a steady increase in the incidence of Clostridium difficile- associated diarrhea (CDAD), a disease that is now epidemic in parts of North America and Eu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/06 - 05/31/08

DESCRIPTION (provided by applicant): Respiratory disease remains the primary cause of morbidity and mortality worldwide due to infectious disease such as community acquired respiratory tract infections (RTIs). Beta-lactam or macrolide antibiotics are currently, a first line of treatment for most RTIs, however, a considerable number of pathogens...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/10/05 - 07/31/06

DESCRIPTION (provided by applicant): Osteoarthritis (OA) is the most common joint disease, currently affecting approximately 40 million Americans. The central pathogenetic mechanism in OA is an aberrant cartilage matrix remodeling process with loss of cartilage cells and matrix, resulting in biomechanical joint failure and inflammation. Loss of ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/05 - 06/30/06

DESCRIPTION (provided by applicant): Clostridium difficile-associated diarrhea (CDAD) is a significant problem in hospitals and long-term care facilities. The primary risk factor for CDAD is treatment with broad spectrum antibiotics which disrupt the gut flora and allow the overgrowth of C. difficile. Current treatments for the disease have sev...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/15/05 - 05/31/06

DESCRIPTION (provided by applicant): Respiratory disease remains the primary cause of morbidity and mortality worldwide due to infectious disease such as community acquired respiratory tract infections (RTIs). Beta-lactam or macrolide antibiotics are currently, a first line of treatment for most RTIs, however, a considerable number of pathogens...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/04 - 09/30/04

Macrolide antibiotics have been marketed since the early 1950's and have a history of being safety and efficacious. These molecules inhibit protein synthesis by interacting with bacterial ribosomal RNA subunits. The recent emergence of macrolide resistance among respiratory tract pathogens has motivated further research in this field. The sugar ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/03 - 10/31/05

DESCRIPTION (provided by applicant): Osteoarthritis (OA) represents the most common joint disease, affecting approximately 40 million Americans. OA is a leading cause of severe activity limitations and disability. Therapies that definitively alter the course of the disease are not available. Pharmacologic management of OA is limited to pain con...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/03 - 02/28/04

DESCRIPTION (provided by applicant): Aminoglycosides (AMGs) are an important class of antibiotics, which are active against a broad rage of difficult to treat bacterial infections. AMGs are particularly useful for the treatment of serious Gram-negative infections resulting from Pseudomonas aeruginosa. AMG resistance in P. aeruginosa continues...

Load More